- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
NCCN Releases Patient Guidelines for Neuroendocrine Tumors
This week, the National Comprehensive Cancer Network (NCCN) published new guidelines for patients centered around neuroendocrine tumors.
This week, the National Comprehensive Cancer Network (NCCN) published a new set of guidelines for patients centered around neuroendocrine tumors (NET).
NET can occur in many different parts of the body, varies in symptom presentation, and can require individualized and oftentimes complicated treatment approaches. These updated guidelines offer the latest information in order to assist patients and caregivers in making knowledgeable, shared medical decisions with the help of their provider.
“Neuroendocrine tumors are complicated and the treatment paths are varied because the disease presents and behaves different in each patient. The NCCN Patient Guidelines offer a common ground of understanding so patients and providers can work as a team to achieve the best possible care,” said Cindy Lovelace, patient and co-founder of The Healing NET Foundation in a statement.
The information provided in the guidelines is based on evidence and expert consensus in clinical practice guidelines created by NCCN’s multidisciplinary panels from 27 leading academic cancer centers throughout the United States. The guidelines cover all aspects of NET, including tests used to diagnose the tumors, an overview of the different treatments offered, and specific treatment guides depending on where the tumors occur in the body.
Formatted specifically for patients, the guidelines and treatment recommendations are presented in user-friendly terms and include illustrations and a glossary to make the information easily digestible.
“It really takes a multidisciplinary team to treat these tumors. Everybody plays a different role in the care of NETs, including endocrinologists, medical oncologists, surgical oncologists, radiation oncologists, and sometimes nuclear medicine radiologists,” said Whitney Goldner, MD, Fred and Pamela Buffett Cancer Center. “These guidelines help prepare patients for the group of people who will comprise their treatment team, and ensure they understand the need for specific testing and therapies for their tumor.”
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer
April 9th 2025New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with metastatic pancreatic cancer are less likely to receive recommended treatments and achieve longer survival.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
